Furthermore, it has recently been shown that pre-invasive ovarian mucinous tumors are characterized by cyclin-dependent kinase inhibitor 2A (CDKN2A) and Ras pathway aberrations [20]. Here, CDKN2A is linked to ovarian mucinous neoplasm.